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T-type Calcium Channels Involved In Collagen 
Fragment-Induced Smooth Muscle Cell Death 
M. Hénaff PhD, J.F. Quignard PhD, N. Biendon, J.L. Morel PhD*, N. Macrez PhD* 
  
Abstract— Apoptosis of smooth muscle cells (SMC) due 
to changes in extracellular matrix has emerged as an 
important factor underlying vascular and visceral disease 
progression. The calcium signal induced by extracellular 
matrix fragmentation also plays a pivotal role in cell death 
and disease evolution. Here, we found that KDGEA, a 
particular motif of type I collagen, induced rat duodenal 
SMC death in cultures through specific interaction with 
α2β1 integrin signaling as suggested by (1) the absence of 
KDGAA effect, an inactive analog of KDGEA, or LDV, a 
fibronectin fragment that recognizes α4β1 integrin, and (2) 
the inhibition of SMC death induced by KDGEA when α2β1 
expression was knocked down by antisense oligonucleotide. 
DNA fragmentation was also detected in KDGEA-treated 
cells, thus suggesting activation of an apoptotic process. 
These KDGEA-activated processes were totally blunted by 
pharmacological modulation of Ca2+ entry through T-type 
Ca2+ channels and antisense oligonucleotides directed 
against these channels. KDGEA also increased 
caffeine-induced calcium release and this effect was 
abolished when cultures were treated with either antisense 
oligonucleotide or T-type channel blockers. These results 
suggested that type I collagen peptide KDGEA can induce 
the death of SMC through T-type Ca2+ channel activation 
and alteration of calcium release from sarcoplasmic 
reticulum. 
 
 
Keywords — apoptosis, calcium entry, extracellular matrix, 
integrin  
 
 
I. INTRODUCTION 
ANY diseases are associated with extracellular matrix 
(ECM) remodeling characterized in some cases by a 
pronounced type I collagen deposition, as observed during 
tissue fibrosis and remodeling (
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1, 2). For example, in 
scleroderma, collagen degradation coincides with SMC 
rarefaction surrounded by areas of focal fibrosis (3) resulting in 
hypomotility, lumen dilatation, tensile rigidity and loss of 
organ functions (4) in pulmonary, peripheral vascular, renal, 
cardiac and gastrointestinal systems.  In vessels, atherosclerosis 
lesions are rich in type I and III collagens constituting up to 
60% of the total plaque proteins (5) that contribute to plaque 
stability. As atherosclerosis progresses, degradation of fibrous 
cap collagens and SMC apoptosis coincide with sites of plaque 
rupture and have both been implied in pathogenesis (6, 7). In 
other vascular diseases such as aneurysms and dissections of 
ascending aorta, the inflammatory process leads to 
protease-mediated degradation of ECM and collagen 
disruption. These processes act in concert with SMC death to 
progressively weaken the aortic wall, resulting in dilatation and 
aneurysm formation or aortic dissections (8, 9). 
Although contribution of collagen remodeling and 
SMC death to various diseases has been well documented, 
precise mechanisms involved in this phenomenon remain 
unclear.  
Integrins represent a large family of 24 ECM receptors 
with different ligand specificity, in which α1β1, α2β1, α10β1 and 
α11β1 form a subset of collagen-binding integrins (10). ECM 
binding to integrin can change intracellular Ca2+ concentration 
([Ca2+]i) in many cell types including platelets, neutrophils, 
monocytes, lymphocytes, fibroblasts, endothelial, epithelial 
and SMC. As a result, a myriad of cellular functions such as 
differentiation, contraction, relaxation or apoptosis are affected 
(11-13). In vascular smooth muscle for example, damage to 
ECM after tissue injury or remodeling could be involved in 
vascular tone modulation. Indeed, the use of peptides and 
specific antibodies showed that ligands of α5β1 or α4β1 
(fibronectin receptors) and αvβ3 (vitronectin receptor) integrins 
reciprocally regulated Ca2+ flow through L-type Ca2+ current in 
myocytes of rat skeletal muscle arterioles (12-14). 
Disturbances of Ca2+ regulation by sarcoplasmic 
reticulum (SR) can play an important role in cell death (15). SR 
Ca2+ overload or depletion can lead to calpain activation, which 
induces apoptosis through BAD, Bid and caspase-12 (16). 
These studies suggest a strong link between abnormal myocyte 
Ca2+ handling, SR and cell death. 
Here, we investigated the role of KDGEA 
(Lys-Asp-Gly-Glu-Ala), a short soluble collagen type I-derived 
motif specifically recognized by the collagen-binding integrin 
M
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α2β1 (17) on SMC survival and Ca2+ signaling. We found that 
KDGEA induced SMC death via Ca2+ entry through T-type 
Ca2+ channels causing SR Ca2+ signal alteration. 
 
II. METHODS 
Cell culture - Investigations conform to the European 
Community and French guiding principles for care and use of 
animals. Authorization to perform animal experiments 
(A-33-00031 to NM) was obtained from the Préfecture de la 
Gironde (France). Rat duodenum SMC were obtained as 
previously described (18). Then, SMC were seeded on glass 
slides (density: 103 cells/mm2) in 24-well plates and maintained 
in short term primary culture (37°C, 95% air, 5% CO2) for 
6 days in M199 medium containing 10% fetal calf serum, 
20U/ml penicillin and 20µg/ml streptomycin. Before treatment, 
SMC cultures were serum-deprived to 0.5% serum overnight.  
Cell Treatment - KDGEA (Lys-Asp-Gly-Glu-Ala), KDGAA 
(Lys-Asp-Gly-Ala-Ala) and LDV-containing peptide 
(Glu-Ile-Leu-Asp-Val-Ser-Pro-Thr) were purchased from 
Eurogentec (Serain, Belgium). For survival assessment, 
peptides were added to cultures (day 6) at different 
concentrations (10 to 200 µM) for 24 hours before analysis by 
WST-1 test or DNA gel electrophoresis. In some experiments, 
1,2-bis(2-aminophenoxy)-ethane-N,N,N',N'-tetraacetic acid 
tetra acetoxymethyl ester (BAPTA-AM, 10 μM, 
Fluoprobes-Interchim, France) was added for 30 minutes and 
removed before KDGEA addition. In other experiments, 
pharmacological drugs such as Nickel (Ni2+, 50 µM), 
Mibefradil (1 µM), Pimozide (1 µM), Isradipine (1 µM), 
Verapamil (10 µM), purchased from Sigma-Aldrich, were 
applied 30 minutes before KDGEA-treatment. In calcium and 
electrophysiological experiments, peptides were added 3 hours 
before analyzes. 
Survival assessment -  SMC cultures grown to confluence in 
24-well plates were treated in quadruplicate for 24 hours as 
indicated above. At the end of experiment, cells were washed 
with PBS. Remaining viable adherent cells were assessed using 
WST-1 test following manufacturer’s instructions (Roche 
diagnostic, France). Briefly, WST-1 diluted to 1/10 in culture 
medium was added and plates were incubated (37°C, 30 
minutes). The absorbance was measured at 440 nm. Each 
experiment was performed in quadruplicate in 3 independent 
cultures. 
DNA ladders - In order to determine DNA ladder 
fragmentation, a hallmark of apoptosis, cell cultures used for 
WST-1 test were further submitted to total genomic DNA 
extraction using DNA preparation kit from Epicentre 
(Madison, WI, USA) and according to manufacturer’s 
instructions. DNA concentration was analyzed by 
biophotometer (Eppendorf, Le Pecq, France) and 10 µg was 
separated by 2% agarose gel electrophoresis containing 0.5 
µg/mL ethidium bromide. Gels were photographed under UV 
illumination by EDAS120 and analyzed with KDS1D 2.0 
software (Kodak Digital Science, Paris, France). Experiments 
were performed in duplicate in 3 independent cultures. 
RT-PCR reactions -  Total RNA was extracted using RNA 
preparation kit (Epicentre, Madison, WI), following supplier 
instructions. Three conditions were tested: RNA from 
longitudinal layers of duodenal smooth muscle (DR), from 
SMC freshly isolated (J0) or from our model of cell cultured for 
6 days in control (J6) or after antisense oligonucleotide 
treatment. RNA concentration was determined by 
biophotometer (Eppendorf, Le Pecq, France). Reverse 
transcription and polymerase chain reactions were performed 
as described previously using Qiagen kits (Qiagen, Hilden, 
Germany) (18). PCR annealing temperatures were: 59.2°C, 
57.5°C or 60°C for α2, α4 integrins or T-type channel primer 
pairs, respectively. Sense (s) and antisense (as) 
oligonucleotides were designed using lasergene software 
(DNASTAR, Madison, WI, USA) according to sequences 
deposited in GenBank (accession numbers BC099151, 
NM001107737 for α2 and α4 integrins, respectively). 
Nucleotide sequences for each primer pair were: α2: s: 
5'-TGACCGGATACAAACAGACAAG-3', as: 5'-CATAGC 
CAACAGCAAAAGGATTC-3', α4: s: 5'-CAATGCCTCGGTG 
GTCAATCCT-3', as: 5'-GGGCCCCCATCACAATCAAA 
T-3', β2-microglobuline: s: 5'-ATTCAGAAAACTCCCCAA 
ATTCAAGT-3', as: 5'-GATTACATGTCTCGGTCCCAGG 
T-3'. In some experiments, amplicon relative amounts were 
determined and normalized to that of β2-microglobuline. Each 
experiment was repeated twice in 3 independent experiments. 
Antisense oligonucleotide treatment - Phosphorothioate 
antisense oligonucleotides labelled by 5′-Cy5 indocarbocyanin 
to visualize cellular uptake were designed based on rat α2 
integrin sequence in regions lacking known splice variants 
(asα2: 5'-CCCGGTCAGATACAGGAGTG-3') and synthesized 
by Eurogentec. T-type calcium channel phosphorothioate 
antisense oligonucleotide has been previously published 
(asCaV3: 5'-TCCACCACCACGCCCACAAACATGTT-3') 
(19). To set free results from Jet-Pei™ transfection, we used as 
control the sequence 5'-TCACCCAGCACCCCCAACAC 
ATAGTT-3' named scrambled (SCR) which was not 
complementary to any rat registered nucleotide sequences. 
Antisense oligonucleotides (50 nM) were reconstituted in NaCl 
150 mM before transfection in myocytes cultured for 2-4 days 
with Jet-Pei™ solution according to manufacturer’s 
instructions. Experiments were performed in 3-5 independent 
cultures. 
Membrane current recordings - Voltage-clamp and 
current-clamp recordings were made with a standard 
patch-clamp technique using List EPC-7 patch-clamp amplifier 
(Darmstadt-Eberstadt, Germany). Whole-cell recordings were 
performed at room temperature with patch pipettes (resistances: 
2-5 MΩ). Membrane potential and current records were 
analyzed using Pclamp system software (Molecular Devices, 
Foster City, CA). Junction potential was electronically 
compensated before acquisition with EPC-7 patch-clamp 
amplifier (7.1 ± 1 mV, n=5 for K+ solution and 4.5 ± 0.8 mV for 
Cs+ solution). T-type currents were measured by test pulse 
from -80 to -30 mV, a potential where T-type channels were 
mostly activated. L-type currents were measured at 0 mV from 
a holding potential of -60 mV where T-type channels are 
inactivated (20). Cells were superfused with extracellular 
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solution (Ca2+ solution) containing (mM): 130 NaCl, 5.6 KCl, 
1 MgCl2, 2 CaCl2, 11 glucose, 10 HEPES, pH 7.4 with NaOH. 
The basic pipette solution (K+ solution) contained (mM): 5 
NaCl, 50 KCl, 65 K2SO4, 2 MgCl2, 2 ATP, 10 HEPES, pH 7.3 
with KOH. To record the T-type current more accurately, 
without contamination by K+ currents, an intracellular Cs+ 
solution was used (mM): 130 CsCl, 10 EGTA, 5 ATPNa2, 2 
MgCl2, 10 HEPES, pH 7.3 with CsOH. Drugs were applied on 
cells via pressure ejection from a glass pipette. 
[Ca2+]i measurement - Measurements of free [Ca2+]i were 
assessed as described previously (21, 22). Briefly, myocytes 
were loaded (30 minutes, 37°C) with membrane permeant Ca2+ 
dye indo-1-AM (10 μM, Molecular probes-Interchim, France). 
Fluorescence intensities (F405and F485) were measured for 
one excitation (λex 340 nm) at two emission wavelengths (λem 
405 and 485 nm). Changes in [Ca2+]i were estimated from the 
changes in the F405/F480 fluorescence ratio (R) as described 
previously (23). Rbasal is the R value obtained in basal 
conditions (during 10 s before stimulation). Response 
amplitudes are expressed as ΔR /Rbasal (deltaR = maximal R 
value obtained after stimulation - Rbasal). Caffeine was applied 
by pressure ejection from a glass pipette. All experiments were 
carried out at 26±1°C. 
Statistical analysis - Student's t-tests or for multiple 
comparisons, one way ANOVA combined with Dunnett and 
Student-Newman-Keuls post-hoc test were used and 
considered significant at p<0.05. Results are presented as 
mean±s.e.m. and n is the number of independent experiments. 
 
III. RESULTS 
KDGEA peptide induced smooth muscle cell death. 
KDGEA is a particular soluble motif of type I collagen that 
specifically recognizes α2β1 integrin [17]. To assess peptide 
effects on cell survival, duodenal SMC primary cultures were 
treated by KDGEA increasing concentrations for 24 hours.  
 
Fig. 1. KDGEA-induced apoptosis of duodenal SMC in culture. A. Statistical 
representation of myocyte survival assessed by WST-1 method after 24h 
treatment with KDGEA, KDGAA (100 µM) or LDV-containing peptide 
(100 µM), (n=3 in quadruplicate; ***p<0.001). B. KDGEA-induced 
internucleosomal DNA cleavage. C. RT-PCR expression of α2 and α4 integrins 
in duodenal smooth muscle tissue (DR), and duodenal smooth muscle cells 
freshly isolated (J0) or cultured for 6 days (J6). 
 
For low concentrations (10, 50 µM), KDGEA did not modify 
cell survival (96.8±1.1% and 94.7±2.4%, respectively, n=3) 
assessed using WST-1 test (Fig. 1A). However, for higher 
concentrations (100, 200 µM), KDGEA dramatically reduced 
myocyte survival (62.7±2.5%, n=10 and 54.3±1.2%, n=3, 
respectively, p<0.001 vs control). Oligonucleosomal-length 
DNA fragmentation, a hallmark of apoptosis (24), was detected 
by agarose gel electrophoresis (Fig. 1B) suggesting that 
KDGEA (100 µM) induces cell death through an apoptotic 
mechanism.  
Other peptides were tested on myocyte survival to check 
whether KDGEA cell death was mediated specifically by α2β1 
integrin. These experiments showed that neither KDGAA 
(100 µM), the inactive analog of KDGEA, nor LDV-containing 
peptide (100 µM), a fibronectin sequence that specifically binds 
α4β1 integrin, induced cell death (104.6±4.9%, n=4 and 
92.0±5.8%, n=3, respectively, NS vs control) (Fig. 1A). This 
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result was corroborated by the absence of oligonucleosomal 
DNA fragmentation (Fig. 1B). α2 and α4 integrin expressions in 
longitudinal layers of duodenal smooth muscle as well as in 
SMC freshly isolated or cultured for 6 days were confirmed by 
RT-PCR (Fig. 1C). 
To confirm that KDGEA-induced cell death was mediated 
through α2β1 integrin activation, we used two antisense 
oligonucleotides, one to inhibit α2β1 expression, and a 
scrambled one used as control to set results free from Jet-Pei™ 
transfection. To demonstrate antisense oligonucleotide 
efficiency, we analyzed endogenous α2 mRNA expression by 
RT-PCR in tested conditions. Values are expressed as relative 
α2 mRNA amounts compared to β2-microglobuline levels 
(Fig. 2A). The α2 expression was comparable in control and 
SCR conditions, whereas it was dramatically decreased in 
asα2-treated cultures.  
F
ig. 2. A. Evaluation of antisense oligonucleotides directed against α2 integrin 
by RT-PCR expressed as the ratio of α2 integrin to β2-microglobuline 
(Falpha2/Fbeta2M) expression (n=3). B. Statistical representation of SMC survival 
assessed by WST-1 method, in control- or KDGEA-treated cells for 24h, 
following 3 days of asα2-treatment (n=3 in quadruplicate;  ***p<0.001). 
 
In these conditions, in the absence of KDGEA, cell survival 
showed no difference between SCR and as-α2-treated 
conditions (Fig. 2B). In contrast, after KDGEA application 
myocyte survival was highly reduced in SCR conditions 
(55.4±7.1% n=3, p<0.001) but not in as-α2-knockdown cultures 
(99.9±4.4%, n=3; Fig. 2B). 
Taken together, these results indicated that KDGEA induced 
duodenal SMC death through specific interaction with α2β1 
integrin signaling. 
 
KDGEA-induced cell death was sensitive to calcium entry 
through T-type calcium channels. 
Changes in [Ca2+]i are involved in numerous intracellular 
events, including triggering of cell death [24,25]. By buffering 
intracellular Ca2+ to assess its putative role in our apoptotic 
model, we found that BAPTA-AM (10 µM), a permeant Ca2+ 
chelator, totally blunted KDGEA-induced cell death 
(102.9±15.3%, n=3 independent cultures, NS vs control) 
(Fig.. 3A) and suppressed oligonucleosomal DNA 
fragmentation (data not shown). 
 
Fig. 3. Pharmacological assessment of calcium sensitivity and entry in 
KDGEA-induced apoptosis. A. Statistical representation of myocyte survival 
assessed by WST-1 method in conditions that modulated [Ca2+]i and calcium 
entry without (open bars) or with KDGEA treatments (black bars; n=4 
experiments in quadruplicate. ***p<0.001 as compared to CTL). B. RT-PCR 
expression of T-type Ca2+ channel pore-forming α1 subunits (α1G, α1H, α1I) of 
duodenal smooth muscle tissue (DR), and duodenal smooth muscle cells 
freshly isolated (J0) or cultured for 6 days (J6).  
 
The putative extracellular origin of Ca2+ was first assessed 
pharmacologically. In control conditions, Ca2+ channel 
blockers did not modify cell survival (Fig. 3A). In the presence 
of KDGEA, inhibitors of L-type Ca2+ channels, namely 
Verapamil (10 µM) and Isradipine (1 µM) did not modify 
KDGEA-induced apoptosis while T-type Ca2+ channel blockers 
Pimozide (1 µM), Mibefradil (1 µM) or Nickel (50 µM) totally 
abrogated it (Fig. 3A). Moreover, RT-PCR analysis revealed 
that in duodenal smooth muscle as well as in SMC freshly 
isolated or cultured for 6 days, expression of α1G and α1H 
subunits but not of α1I were detected (Fig. 3B). 
Voltage-gated Ca2+ currents were recorded by a standard 
patch-clamp technique to functionally confirm their presence in 
duodenal smooth muscle cells. Figure 4A represents a typical 
whole-cell Ca2+ current with a two-component inward current 
evoked by a long depolarization pulse from -80 to -10 mV. 
Each component could be isolated on the basis of their voltage 
dependence of activation and inactivation. The first component 
was a transient peak inward current (open square) that 
presented typical features of T-type Ca2+ currents (22). This 
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transient component was followed by a sustained inward 
component (filled square) that was activated for higher voltage 
step and inactivated more slowly (Fig. 4A-B), as described for 
L-type calcium currents (22). 
 
Fig. 4. Functional and pharmacological assessment of T- and L-type Ca2+ 
channels in rat duodenal SMC. A. Typical current elicited by a step 
depolarization from -80 to -10 mV, showing a transient peak current (□, due to 
T-type channels) followed by a sustained current (■, due to L-type channels) 
and current-voltage relationship measured at the peak (□) and the end of the 
pulse (■): transient current was activated for lower voltage step (characteristics 
of T-type channels) than for sustained high voltage-activated L-type channels 
(holding potential -80 mV). For a step depolarization to -30 mV, the current 
was mainly due to T-type channels activities. B. 50 µM Ni2+ almost totally 
inhibited T-type currents (evoked by a step depolarization from -80 to -30 mV, 
open bars in C) while it weakly inhibited L-type currents (evoked by a step 
depolarization to 0 mV just after the first step, black bars in C). C. 
Concentration-dependent effects of Ni2+, Mibefradil, Isradipine and Verapamil 
on T-type (open bars) and L-type (black bars) Ca2+ currents using the protocol 
illustrated in B. Experiments were performed in extracellular Ca2+ solution, and 
intracellular Cs+ solution. 
Having demonstrated that T- and L-type currents coexist in 
duodenal SMC, we tested if their pharmacological profile was 
consistent with survival data obtained previously. T-type 
currents were elicited by test pulse from -80 to -30 mV, a 
potential where they were mostly activated. L-type calcium 
currents were measured at 0 mV from a holding potential of 
-30 mV, a holding potential where T-type channels were 
inactivated (22). In these conditions, Nickel application 
(50 µM) inhibited T-type currents but partially reduced L-type 
currents (Fig. 4B). The ability of Calcium channel blockers to 
discriminate between T-type and L-type currents is 
summarized in Figure 4C. These results showed that Mibefradil 
(1 µM) inhibited preferentially (~70%) T-type currents, 
whereas Isradipidine (1 µM) and Verapamil (10 µM) produced 
a significant inhibition of L-type currents with a lower 
alteration of T-type currents. 
To confirm T-type channels’ involvement in 
KDGEA-induced cell death, we used two antisense 
oligonucleotides, one to inhibit the expression of T-type 
channels (asCav3), and a scrambled one used as control to set 
results free from Jet-Pei™ transfection. RT-PCR expression of 
T-type channels detected previously was used to assess 
antisense oligonucleotide efficiency (Fig. 5A). Values are 
expressed as relative α1G and α1H mRNA amounts compared to 
β2-microglobuline levels. α1G and α1H mRNA expressions were 
comparable in control and SCR conditions, whereas they were 
dramatically decreased in asCav3-treated cultures.  
 
Fig. 5. Inhibition of T-type channel expression by antisense oligonucleotide 
(asCav3) suppressed KDGEA-induced apoptosis. A. RT-PCR assessment of 
asCav3 treatment against α1G and α1H isoforms previously detected (maximal 
effect on mRNA expression measured 3 days after transfection). Fluorescence 
ratios of α1G (Fα1G/Fbeta2M, open bars) and α1H (Fα1H/Fbeta2M, black bars) to 
β2-microglobuline indicated the relative mRNA expression in control, 
scrambled- or asCav3-treated cells (***P<0.001; n= 3 in duplicate). B. 
Statistical representation of SMC survival assessed by WST-1 method, in 
control- or KDGEA-treated cells, following a 3-day asCaV3 treatment 
(***p<0.001; n= 3 in quadruplicate). 
 
In these conditions, myocyte survival assessment showed no 
significant differences between SCR and asCav3 cultures 
(Fig. 5B). However, in KDGEA-treated cells myocyte survival 
was highly reduced in SCR condition, whereas in asCav3 
condition KDGEA did not modify myocyte survival. 
All together, these results suggested that the KDGEA 
impairment of SMC survival was highly dependent upon 
calcium entry through T-type calcium channels. 
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KDGEA treatment enhanced calcium entry and modified 
sarcoplamic reticulum calcium signaling. 
We further examined the regulation of calcium entry through 
T-type calcium channel by measuring the effect of KDGEA 
peptide on T-type current activated by a step depolarisation 
from -80 to -30 mV. The transient increase in [Ca2+]i in 
3h-KDGEA-treated cells was higher than in control cells, as 
illustrated in Figure 6A and 6B.  
 
Fig. 6. KDGEA-treated cells exhibited a higher [Ca2+]i increase induced by 
T-type channel activities. A. Typical Ca2+ response elicited by a step 
depolarization from -80 to -30 mV in control condition or after a 3h-KDGEA 
treatment. B. Statistical representation of basal [Ca2+]i after a 3h-KDGEA 
treatment (left) and KDGEA calcium response elicited by a step depolarization 
(right). Calcium responses were measured as difference between resting basal 
level and peak of Ca2+ transient. Cells were loaded with indo-1-AM (*p<0.05; 
n=7 experiments).  
 
Since calcium entry could induce apoptosis through 
alteration of [Ca2+]i, mitochondrial and/or SR Ca2+ contents 
(25), [Ca2+]i changes were recorded using indo-1-AM, in 
resting conditions or following short applications (10 seconds) 
of either (1) CCCP, a mitochondrial uncoupler that triggers 
Ca2+ release from mitochondria (25), or (2) caffeine, an 
activator of ryanodine receptor that triggers Ca2+ release from 
SR. In 3h-KDGEA-treated cultures, basal [Ca2+]i did not differ 
from control conditions (1.37±0.03, n=16 cells in 
KDGEA-treated conditions vs 1.34±0.04, n=20 cells in control) 
(Fig. 6B), suggesting that cytosolic calcium homeostasis was 
conserved during the first hours of KDGEA application. 
Application of CCCP caused a slow and transient rise in 
[Ca2+]i with no difference between control and KDGEA-treated 
cells (data not shown). In contrast, caffeine application induced 
a transient increase in [Ca2+]i with a magnitude greater in 
KDGEA-treated cells than in controls (Fig. 7A). This signal 
depended upon α2 integrin activation since asα2-treated cultures 
presented a magnitude of caffeine-induced calcium increase 
similar to control levels (Fig. 7B). Moreover, in the presence of 
calcium channel blockers, SR function assessment by caffeine 
application showed that Isradipine did not prevent calcium 
signal increase. In contrast, Mibefradil reduced this 
phenomenon to a control level (Fig. 7B). Furthermore, asCav3 
prevented SR calcium increase evoked by caffeine (Fig. 7B). 
 
Fig. 7. SR-calcium alteration evoked by caffeine (10 mM) in KDGEA-treated 
SMC. A. Intracellular calcium signal recorded following a 10-sec caffeine 
application in control or KDGEA-treated cells loaded with indo-1-AM. B. 
Statistical representation of caffeine-induced [Ca2+]i amplitude in various tested 
conditions (***p<0.001 as compared with CTL,  p<0.001 as compared with 
KDGEA; n=7 experiments).  
Finally, the acute application of KDGEA could increase the 
T-type Ca2+ current by 5% (not shown). 
All together, these results suggested that, in duodenal SMC, 
SR calcium signalling was altered in KDGEA-induced cell 
death through α2 integrin interaction without alterations of 
cytosolic or mitochondrial calcium contents. This phenomenon 
involved Ca2+ entry through T-type calcium channels. 
IV. DISCUSSION 
In this study, we provide several lines of evidence that the 
collagen fragment KDGEA peptide impaired cell survival of 
cultured duodenal SMC through T-type Ca2+ channel activation 
and alteration of SR Ca2+ release. 
We observed a dramatic reduction of cell survival after 
treatment of duodenal SMC with KDGEA (100 µM), a 
fragment of type I collagen. This is in line with previous studies 
which showed that degraded type I collagen can promote 
initiated calpain-mediated disassembly of focal adhesions and 
loss of vascular SMC attachment to ECM (1). This 
phenomenon is at least partly dependent on α2- and αv-integrins 
and could promote SMC proliferation, migration and invasion 
into arterial intima (26, 27). Recently, two studies showed that 
the same type I collagen fragments could either activate 
apoptosis of vascular SMC by calpain-mediated inactivation of 
anti-apoptotic proteins such as xIAP (X-chromosome-linked 
inhibitor of apoptosis), or promote survival by a mechanism 
involving αvβ3-dependent NF-κB activation with consequent 
activation of IAPs (28, 29). Here we showed that, as vascular 
SMC, duodenal SMC also activated a cellular death process in 
the presence of a collagen fragment. This SMC death presented 
the DNA fragmentation feature of apoptosis. Moreover, by our 
peptidic approach, we have identified that the KDGEA 
sequence was sufficient to induce this process. KDGEA 
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contains the minimal active recognition sequence for α2β1 
integrin that corresponds to the 435-438 residues of 
alpha 1(I)-CB3 fragment of type I collagen (17). This collagen 
often predominates in neomatrix of fibrotic smooth muscle 
tissues such as peripheral vascular and gastrointestinal systems 
of systemic sclerosis patients or during progression of 
atherosclerosis (3-9).  
KDGEA-induced cell death seemed independent from 
cellular adhesion since α2β1 integrin knockdown treatment did 
not modify cell survival, as compared to the scrambled 
condition. This is consistent with the fact that α2β1-deficient 
mice are viable, fertile and develop normally (30). This 
suggests that in our experimental model KDGEA played a 
pivotal role in cell death induction through its interaction with 
α2β1 integrin signaling. However fibrosis, and especially 
collagen degradation and turnover, could produce several 
peptides which can present different biological activities. The 
cellular decision between life and death would then be 
governed by integration of signals from all engaged integrins 
and could have an impact on disease progression. 
Whatever was the cell death activated by KDGEA, the 
important feature of this study is that this process could be 
totally blunted by calcium signal modulation. In SMC, as in 
many other cell types, calcium signaling is a universal signal 
transduction mediating extracellular effects of environmental 
signals into a specific cellular response such as contraction, 
proliferation or apoptosis (31). In the osteoblast-like cell line 
SaOS-2 (32) as in human dermal fibroblasts (33), the DGEA 
peptide, which is more acidic than KDGEA, induced Ca2+ 
transient by mobilizing calcium from intracellular stores when 
applied at millimolar ranges. In our study, KDGEA at lower 
concentration (100 µM) impaired cell survival by a 
calcium-dependent mechanism as shown by the suppression of 
cell death in cultures pre-treated with the intracellular calcium 
chelator BAPTA-AM. In SMC, calcium homeostasis is a 
complex process highly controlled by various sarcolemmal 
calcium channels and intracellular calcium stores which may be 
altered during apoptosis. In our model, pharmacological 
modulation of membrane calcium channels or reduction of 
T-type calcium channel expression by antisense 
oligonucleotides blunted KDGEA-induced cell death. This 
suggested that KDGEA interaction with α2β1 integrin reduced 
cell survival via calcium entry through T-type calcium 
channels. Few studies have reported that pharmacological 
inhibition of T-type calcium channels could protect against 
apoptosis. For example, T-type calcium channel blockers 
Mibefradil, Kurtoxin, Nickel, Zinc or Pimozide protected 
neurons from delayed ischemia-induced damage (34). In a 
spermatogenic cell model, Mishra et al. showed that 
2,5-hexanedione, a metabolite of the industrial solvent 
n-hexane, caused a significant increase in reactive oxygen 
species followed by [Ca2+]i enhancement inhibited by 
Pimozide. This calcium entry through T-type channels altered 
the Bcl-xS to Bcl-xL ratio, leading to mitochondrial changes 
resulting in apoptotic death (35). Because of the weak 
specificity of T-type channel blockers, our results using 
antisense oligonucleotide were the first direct demonstration 
that, in SMC, T-type channel activation was involved in cell 
death induction. Moreover, interaction between α2β1 integrin 
and its ligand KDGEA was needed for their activation.  
Several lines of evidence suggest that L-type channels are 
regulated by integrin-dependent signaling. In vascular SMC for 
example, at least three different integrins modulate their 
activity and alter vascular tone in arterioles. Whole-cell 
recordings show that insoluble and soluble αvβ3 integrin ligands 
(RGD peptides, vitronectin and fibronectin fragments) inhibit 
L-type currents and elicit vasodilatation (13). In contrast, 
soluble α4β1 (LDV peptide) as well as insoluble α5β1 ligands 
enhance L-type calcium currents and vasoconstriction (13, 14), 
indicating that ECM interactions with integrins modulate 
vascular tone. 
However, T-type channels are quantitatively a weak source 
of calcium entry compared with L-type channels or with SR 
calcium release during smooth muscle contraction. Thus, our 
observations raise the question as to how T-type channels can 
have a specific effect on SMC death. In cardiac myocytes for 
example, persistent increases in calcium influx through L-type 
channels induced SR calcium overload, correlated with 
apoptosis induction (36). In another study, SR calcium 
overload or depletion activated calpains, which induced 
apoptosis through BAD, Bid and caspase-12 (16). Interestingly, 
T-type channels can sustain a continuous calcium influx by a 
window current mechanism, corresponding to a voltage range 
where a channel population fraction is always opened and does 
not inactivate (20). This property could be responsible for the 
increase in caffeine-induced calcium release observed in 
KDGEA-treated SMC. Indeed, in cells treated with T-type 
inhibitors or antisense oligonucleotides, KDGEA-induced cell 
death was blunted and caffeine-induced SR calcium signal 
returned to a control level. Taken together, these results suggest 
a possible increase in SR calcium loading. This is in agreement 
with studies showing that SR is a component of inducible 
apoptosis (37). Indeed, SERCA overexpression in 
non-myocytes was shown to be proapoptotic (38), whereas 
cells devoid of SR Ca2+ release channels (IP3 receptor) are 
resistant to apoptosis (39). In addition, proapoptotic Bcl-2 
proteins (BAX and BAK) induced apoptosis in part by 
increasing SR content, whereas antiapoptotic Bcl-2 proteins 
protected by decreasing SR calcium content (15, 37, 40). More 
recently, a study performed on spermatogenic cells showed that 
Ca2+ entry through T-type channels could regulate the ratio of 
proapoptotic Bcl-xS and antiapoptotic Bcl-xL expression (35). 
However, our study could not exclude an enhanced ryanodine 
receptor activity. Indeed, in SMC, RGD-containing ligands can 
also mobilize ryanodine-sensitive Ca2+ stores through increased 
cyclic ADP ribose, the endogenous activator of ryanodine 
receptors (41).  
 T-type Ca2+ channels have been suggested to be implicated 
in cell death via integrin pathway because Mibefradil could 
activate apoptosis via the modulation of membrane potential 
and the modification of integrin expression in HLE-B3 cell line 
(42). Our results showed thatintegrin activation by KDGEA 
increases the window current of T-type Ca2+ channels the SR 
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Ca2+ loading and/or Ca2+-induced Ca2+ release known to 
activate apoptosis. The pathway between integrin and T-type 
Ca2+ channel activation remains unknown.However, 
integrin-activated increases of L-type Ca2+ channel activity 
involved phosphorylation of the channel (43) by src and PKA 
(44, 45). T-type Ca2+ channels has also been shown to be 
activated via PKA in SMC (46) and src in neuroblastoma cell 
line (47). Therefore, PKA and src are good candidates to link 
T-type Ca2+ channels activation to integrin stimulation by 
KDGEA in SMC. 
 
V. CONCLUSIONS 
Collectively, these data suggest a crucial role for T-type 
channel activation and SR calcium signal in smooth muscle cell 
death induced by KDGEA. This study could give new 
perspectives of treatment in pathogenesis processes in which 
SMC rarefaction coincide with type I collagen deposition and 
alteration of Ca2+ signaling. 
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